Beasley, G. M., VanderWalde, A. M., Bowles, T. L., Sacco, J. J., Niu, J., Tsai, K. K., … Milhem, M. M. (2023). Safety, Efficacy, and Biomarker Assessment of RP1 in Combination With Nivolumab in Patients with Advanced Skin Cancers. In ANNALS OF SURGICAL ONCOLOGY (Vol. 30, pp. S9–S10).

Beasley, Georgia M., Ari M. VanderWalde, Tawnya L. Bowles, Joseph J. Sacco, Jiaxin Niu, Katy K. Tsai, Jason A. Chesney, et al. “Safety, Efficacy, and Biomarker Assessment of RP1 in Combination With Nivolumab in Patients with Advanced Skin Cancers.” In ANNALS OF SURGICAL ONCOLOGY, 30:S9–10, 2023.

Beasley GM, VanderWalde AM, Bowles TL, Sacco JJ, Niu J, Tsai KK, et al. Safety, Efficacy, and Biomarker Assessment of RP1 in Combination With Nivolumab in Patients with Advanced Skin Cancers. In: ANNALS OF SURGICAL ONCOLOGY. 2023. p. S9–10.

Beasley, Georgia M., et al. “Safety, Efficacy, and Biomarker Assessment of RP1 in Combination With Nivolumab in Patients with Advanced Skin Cancers.” ANNALS OF SURGICAL ONCOLOGY, vol. 30, no. SUPPL 1, 2023, pp. S9–10.

Beasley GM, VanderWalde AM, Bowles TL, Sacco JJ, Niu J, Tsai KK, Chesney JA, Chmielowski B, Samson A, Rhodes TD, In GK, Pavlick AC, Wise-Draper TM, Sanmamed MF, Hou J, Middleton MR, Harrington K, Lebbe C, Michels J, Milhem MM. Safety, Efficacy, and Biomarker Assessment of RP1 in Combination With Nivolumab in Patients with Advanced Skin Cancers. ANNALS OF SURGICAL ONCOLOGY. 2023. p. S9–S10.